@article{96459b1e4e7b4cf4a2c3aa9fea564fb9,
title = "Should docetaxel be administered earlier in prostate cancer therapy?",
keywords = "chemotherapy, docetaxel, metastatic disease, overall survival, prostate cancer",
author = "Graff, {Julie N.} and Beer, {Tomasz M.}",
note = "Funding Information: JN Graff has received research funding from Sanofi. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.",
year = "2015",
month = sep,
day = "2",
doi = "10.1586/14737140.2015.1074042",
language = "English (US)",
volume = "15",
pages = "977--979",
journal = "Expert review of anticancer therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "9",
}